Yanan Z. Hua
Chengdu, 611137, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Research Progress on the Antitumor Effects of Isorhamnetin (ISO) and Its Molecular Mechanisms.
Journal: Anti-cancer agents in medicinal chemistry
Published: April 13, 2026
Dual-ligand-modified chitosan nanoliposomes for the targeted delivery of germacrone: Effects on mitochondrial apoptosis and ROS-mediated endoplasmic reticulum stress in hepatocellular carcinoma.
Journal: International journal of biological macromolecules
Published: February 13, 2026
Regulator of Ribosome Synthesis 1 (RRS1) Stabilizes GRP78 and Promotes Breast Cancer Progression.
Journal: Molecules (Basel, Switzerland)
Published: February 03, 2024
Ferulic Acid Alleviates Hepatic Lipid Accumulation and Inflammation by Improving Proximal and Distal Intestinal Barriers in NAFLD Mice.
Journal: The Tohoku journal of experimental medicine
Published: March 17, 2023
The Large Molecular Weight Polysaccharide from Wild Cordyceps and Its Antitumor Activity on H22 Tumor-Bearing Mice.
Journal: Molecules (Basel, Switzerland)
Published: March 17, 2023
Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in Breast Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: March 01, 2023
Polysaccharides extracted from mulberry fruits (Morus nigra L.): antioxidant effect of ameliorating H2O2-induced liver injury in HepG2 cells.
Journal: BMC complementary medicine and therapies
Published: January 13, 2023
The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target.
Journal: Cell biology international
Published: August 10, 2022
Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis.
Journal: International journal of oncology
Published: November 04, 2021
Advances in the Relationship Between Regulator of Ribosome Synthesis 1 (RRS1) and Diseases.
Journal: Frontiers in cell and developmental biology
Published: November 14, 2020
TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53.
Journal: Molecular and cellular biochemistry
Published: July 08, 2020
[Corrigendum] MYCN‑amplified neuroblastoma cell‑derived exosomal miR‑17‑5p promotes proliferation and migration of non‑MYCN amplified cells.
Journal: Molecular medicine reports
Published: May 08, 2020
Last Updated: 09/26/2026